<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP07836288B8W1" file="EP07836288W1B8.xml" lang="en" country="EP" doc-number="2076242" kind="B8" correction-code="W1" date-publ="20130220" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..MT..........................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.15 (14 Jul 2008) -  2999001/0</B007EP></eptags></B000><B100><B110>2076242</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20130220</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>07836288.6</B210><B220><date>20070727</date></B220><B240><B241><date>20090227</date></B241><B242><date>20091118</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>833731 P</B310><B320><date>20060727</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20130220</date><bnum>201308</bnum></B405><B430><date>20090708</date><bnum>200928</bnum></B430><B450><date>20121226</date><bnum>201252</bnum></B450><B452EP><date>20120709</date></B452EP><B480><date>20130220</date><bnum>201308</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  38/28        20060101AFI20120531BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K   9/00        20060101ALI20120531BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>SPRÜHBARE FORMULIERUNG MIT INSULIN ZUR PULMONALEN VERABREICHUNG</B542><B541>en</B541><B542>AEROSOLIZABLE FORMULATION COMPRISING INSULIN FOR PULMONARY DELIVERY</B542><B541>fr</B541><B542>FORMULATIONS DE DÉRIVÉS D'INSULINE POUR ADMINISTRATION PULMONAIRE</B542></B540><B560><B561><text>WO-A-02/078675</text></B561><B561><text>WO-A-2005/067898</text></B561><B561><text>WO-A-2008/013955</text></B561><B562><text>"INSULIN INHALATION - PFIZER/NEKTAR THERAPEUTICS" DRUGS IN R &amp; D, ADIS INTERNATIONAL, AUCKLAND, NZ, vol. 5, no. 3, 2004, pages 166-170, XP008066361 ISSN: 1174-5886</text></B562></B560></B500><B700><B720><B721><snm>KUO, Mei-Chang</snm><adr><str>1823 Middlefield Road</str><city>Palo Alto, California 94301</city><ctry>US</ctry></adr></B721><B721><snm>ELDON, Michael Alex</snm><adr><str>3323 Oak Knoll Drive</str><city>Redwood City, California 94062</city><ctry>US</ctry></adr></B721><B721><snm>YUAN, YiQiong</snm><adr><str>1216 Regent Street, Apt. G</str><city>Alameda, California 94501</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>Nektar Therapeutics</snm><iid>101352770</iid><irf>53333-EP-EPT</irf><adr><str>Corporation Trust Center 
1209 Orange Street</str><city>Wilmington, Delaware 19801</city><ctry>US</ctry></adr></B731></B730><B740><B741><snm>Baldock, Sharon Claire</snm><sfx>et al</sfx><iid>100034649</iid><adr><str>Boult Wade Tennant 
Verulam Gardens 
70 Gray's Inn Road</str><city>London WC1X 8BT</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>US2007016903</anum></dnum><date>20070727</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2008013938</pnum></dnum><date>20080131</date><bnum>200805</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
